Log in to search using one of your social media accounts:


Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer

EVANSTON, Ill., Dec. 7, 2017 -- (Healthcare Sales &Marketing Network) -- Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced the appointment of Andy Kidd, B.M.... Biopharmaceuticals, Neurology, Personnel Aptinyx, neuropathic pain, PTSD
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news

Related Links:

More News: Brain | Marketing | Neurology | Pain | Pharmaceuticals | Post Traumatic Stress Disorder